Skip to main content
Show full summary

Lord Hunt of Kings Heath to ask His Majesty's Government whether they are satisfied that the Medicines and Healthcare products Regulatory Agency undertook a sufficiently rigorous approach to the licensing of montelukast, in view of the US Food and Drug Administration’s black box warning about its use.  HL3247

Question HL3247: tabled on 13 March 2024 and due for answer by 27 March 2024

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Hunt of Kings Heath to ask His Majesty's Government whether they are satisfied that the Medicines and Healthcare products Regulatory Agency undertook a sufficiently rigorous approach to the licensing of montelukast, in view of the US Food and Drug Administration’s black box warning about its use.  HL3247
Legend for business item text
Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.